Abbott Laboratories Share Price, PSX Chart & Forecast (PSX: ABOT) Abbott Laboratories (Pakistan) Limited
Rs967.16
Up +43.01 (+4.65%) on the day
As of close · Source: PSX · End-of-day data, not a live feed
ABOT key statistics
Session of 27 Oct 2026 · Select ? beside a label for a plain-English definition
- OpenOpenThe price of the first trade in the session. Glossary
- Rs 929.00
- HighHighThe highest price traded during the period — today's session unless stated otherwise. Glossary
- Rs 978.00
- LowLowThe lowest price traded during the period — today's session unless stated otherwise. Glossary
- Rs 921.00
- Prev closeCloseThe official last price of the session. The day's change is measured from the previous close, and it is the reference for the next session. Glossary
- Rs 924.15
- VolumeVolumeThe number of shares traded in the session. A move on heavy volume carries more conviction than the same move on a quiet day. Glossary
- 66,286
- TurnoverTurnoverThe rupee value of shares traded (volume × price). Pakistani market reports often use "turnover" loosely for the number of shares traded, so check the unit. Glossary
- Rs 64.1M
- Market capMarket capitalisationShare price multiplied by the number of shares outstanding — what the market says the whole company is worth. Use it, not the share price, to compare the size of two businesses. Glossary
- Rs 94.69B
- P/E ratioP/E ratioShare price divided by earnings per share — how many rupees you pay for one rupee of annual profit. Compare it only with companies in the same sector. Glossary
- 11.1
- EPSEPS (earnings per share)Net profit divided by shares outstanding — the company's earnings attributable to one share. Rising EPS over several years is the cleanest evidence a business is growing. Glossary
- Rs 81.37
- Dividend yieldDividend yieldAnnual dividend per share divided by the share price, as a percentage. A very high yield is often a warning: the price may have fallen sharply, and the dividend may be cut next. Glossary
- —
- BetaBetaHow much a stock tends to move relative to the market. A beta of 1 moves with it, above 1 amplifies it, below 1 dampens it — it measures co-movement, not quality. Glossary
- 0.78
- ROEROE (return on equity)Net profit as a percentage of shareholders' equity — how efficiently management turns the owners' capital into profit. Consistently high ROE without heavy debt is a sign of a durable business. Glossary
- —
- Book value / shareBook valueAssets minus liabilities — the company's accounting net worth, usually quoted per share. Glossary
- —
- P/B ratioP/B (price-to-book)Share price divided by book value per share. Below 1 means the market values the company at less than its stated net assets — a reason to investigate, not an automatic bargain. Glossary
- —
- 52-week range52-week rangeThe lowest and highest price over the past year. It shows where today's price sits, but a stock near its 52-week low is not automatically cheap. Glossary
-
836.92967.161,257.76
— means not available. For ABOT that is dividend yield, as no cash dividend from the past twelve months is on file; ROE, book value and P/B, which need audited accounts we do not hold yet. We leave a figure blank rather than estimate it.
ABOT at a glance
What the figures on this page say, in plain English
Strengths
Valued below peers. P/E of 11.1 against a Pharmaceuticals median of 16.1.
Uptrend. Trades above its 20-day (Rs 928.56) and 50-day (Rs 926.12) moving averages.
Model reads bullish. The automated model reads ABOT as bullish at 62% confidence.
Steadier than the market. Beta of 0.78 against the KSE-100: over the past year it moved less than the market.
Cautions
Nothing in the data on this page reads as a clear caution today.
What this means: each line restates a figure for ABOT shown on this page and is recomputed after every session. It describes the data; it is not a recommendation to buy or sell.
Model outlook
rule-engine-v2Strongly bullishAI signalThe model's directional reading of the stock over the next ten sessions, on a five-step scale from strongly bearish to strongly bullish, built from price and indicator history. A description of the data, not investment advice. Glossary
62% confidenceConfidenceHow strongly the model leans toward its call. It is not the probability of being right — the graded record against the base rate is the figure for that. Glossary · Short Term
The model reads ABOT as strongly bullish — an overall score of 69/100 from the rule-based fallback, which is a blend of inputs, not a probability. See the graded record and what drove it ↓
Automated model output, not a recommendation. A reading is a statistical lean; weigh it against the live record in the model card.
ABOT price chart
Daily ABOT prices with 20- and 50-day averages and Bollinger Bands. Drag to zoom; hover for each day's figures.
27 Oct 2025 – 27 Oct 2026: ▼ −18.20% · high Rs 1,257.76 · low Rs 836.92
ABOT share price and analysis
Abbott Laboratories (Pakistan) Limited (ABOT) last traded at Rs 967.16 on the Pakistan Stock Exchange, where it rose 4.65% on the session of 27 October 2026. Volume was 66,286 shares, a turnover of Rs 64.1 million. Over the past year the share has traded between Rs 836.92 and Rs 1,257.76, putting the current price around the middle of that range.
The price is above both its 20-day (928.56) and 50-day (926.12) moving averages, the configuration usually read as an intact uptrend. The 14-day RSI is 67.1, a neutral reading. ADX at 16.8 indicates a weak or rangebound trend.
The company is capitalised at roughly Rs 94.7 billion and is classified under Pharmaceuticals. It trades on a price-to-earnings ratio of 11.1, meaning the market is paying about Rs 11.1 for every rupee of annual earnings. Earnings per share stand at Rs 81.37. A beta of 0.78 against the KSE-100 means the share has moved less sharply than the wider market over the past year.
ABOT is the 2nd largest of the 34 Pharmaceuticals companies we track by market value. Its price-to-earnings ratio of 11.1 compares with the Pharmaceuticals median of 16.1, so it is priced at a clear discount to its sector. Sector medians are taken across the companies we hold fundamentals for and move as those are restated.
Our forecasting model currently reads ABOT as strongly bullish over a short term horizon, at 62% confidence. The model is computed from the price and indicator history shown on this page. It does not read news, financial statements or management changes, and it is not a recommendation to buy or sell.
This summary is generated from the end-of-day prices and indicators shown on this page and is refreshed after each trading session. It describes the data; it is not a recommendation. See how we collect and check this data and our disclaimer.
Other Pharmaceuticals stocks
ABOT is a Pharmaceuticals listing. Compare it against the rest of the sector, or read what actually drives Pharmaceuticals companies on the PSX.
-
GOCGOC (Pak) Limited.222.42▼ −2.78% -
DIILDiamond Industries Limited84.60▲ +9.98% -
PABCPakistan Aluminium Beverage Cans Limited97.03▲ +5.75% -
OMLOlympia Mills Limited79.41▲ +10.00% - CWH CWHCCrestwell Healthcare Limited21.87▼ −3.19%
Learn how to read this page
- How to Read a Stock Page Without Fooling Yourself
A walk through every number on a PSX stock page — price, volume, P/E, RSI, our own AI signal — and an honest account of how much weight each one deserves.
- Technical Analysis on the PSX: Using Moving Averages, RSI and MACD Without Fooling Yourself
Moving averages, RSI and MACD describe past prices — nothing more. Used in the right order they keep you honest; used as signals they lose money. Here are the mechanics that actually work on the PSX, and where thin volume and circuit breakers make indicators meaningless.
- How to Read a PSX Company's Financial Statements
Annual reports are free, audited and almost never read. A walk through a PSX income statement and balance sheet, with EPS, P/E, ROE and dividend yield worked by hand — and the red flags those ratios quietly hide.
ABOT technical indicators — RSI, MACD & moving averages
Momentum and trend gauges for ABOT after the session of 27 Oct 2026, each with a one-line reading of what the number means.
RSI (14)
RSI (Relative Strength Index)A momentum gauge from 0 to 100, usually over 14 days. Above 70 is called overbought and below 30 oversold, but in a strong trend RSI can stay there for weeks — it is not a buy or sell instruction. GlossaryABOT reads 67.1 — neutral (between 30 and 70). Above 70 is conventionally read as overbought, below 30 as oversold; dashed lines mark both.
MACD (12, 26, 9)
MACDThe 12-day exponential moving average minus the 26-day, with a 9-day signal line on top. A cross above the signal line means short-term momentum has turned up; it lags, and misfires in sideways markets. GlossaryABOT reads 5.025 — above its signal line: momentum improving. Bars show the gap between MACD and its signal line.
- RSI (14)
- 67.1
- Neutral (between 30 and 70)
- Stochastic %K
- 82.7
- Overbought zone (above 80)
- ADX (14)ADX (Average Directional Index)Measures trend strength from 0 to 100 without saying which direction. Below about 20 the market is ranging; above 25 a real trend is present. Glossary
- 16.8
- Weak or sideways trend (below 25)
- Williams %R
- -17.3
- Overbought zone (above −20)
- SMA 20SMA 20The average closing price of the last 20 sessions, redrawn each day — a short-term trend line. Moving averages describe what has happened; they do not predict. Glossary
- 928.56
- Price is 4.2% above it
- SMA 50SMA 50The average closing price of the last 50 sessions — the most watched medium-term trend line. Price above a rising 50-day average is a common definition of an uptrend. Glossary
- 926.12
- Price is 4.4% above it
- MACD
- 5.025
- Above its signal line: momentum improving
- ATR (14)
- 9.149
- A typical day moves about 0.9% of the price
- Bollinger upperBollinger BandsA moving average with bands two standard deviations above and below; they widen as volatility rises. Touching the upper band means the price is stretched, not that it must reverse. Glossary
- 956.34
- Price is above the upper band
- Bollinger lower
- 900.78
- Price is 7.4% above it
- Momentum (10)
- 36.91
- Higher than 10 sessions ago
- Technical score
- 81
- Strong, on a 0–100 scale
ABOT fundamentals & valuation ratios
Set beside the median Pharmaceuticals company
| Measure | ABOT | Sector median |
|---|---|---|
| Market cap | Rs 94.69B | No. 2 of 34 by size |
| P/E ratio | 11.1 | 16.1 |
| EPS | Rs 81.37 | — |
| P/B ratio | — | — |
| Dividend yield | — | — |
| ROE | — | — |
| Beta | 0.78 | — |
| Volatility (annualised) | 31.8% | — |
Fundamental score
56/100
What this means: ABOT scores 56 on a 0–100 check built only from the figures we hold for it — P/E and volatility. 50 is neutral; compare it within a sector, not across sectors. A dash in the table is a figure we do not hold for ABOT; it adds nothing to the score rather than being guessed.
ABOT price history — last 30 sessions
Daily open, high, low and close, newest first
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Tue, 27 Oct 2026 | 929.00 | 978.00 | 921.00 | 967.16 | ▲ +4.65% | 66,286 |
| Mon, 26 Oct 2026 | 927.67 | 927.67 | 924.15 | 924.15 | ▼ −0.38% | 7,181 |
| Fri, 23 Oct 2026 | 927.37 | 927.67 | 927.37 | 927.67 | ▲ +0.03% | 28,777 |
| Thu, 22 Oct 2026 | 941.66 | 941.66 | 927.37 | 927.37 | ▼ −1.52% | 3,686 |
| Wed, 21 Oct 2026 | 935.61 | 941.66 | 935.61 | 941.66 | ▲ +0.65% | 11,271 |
| Tue, 20 Oct 2026 | 947.72 | 947.72 | 935.61 | 935.61 | ▼ −1.28% | 2,011 |
| Mon, 19 Oct 2026 | 944.39 | 947.72 | 944.39 | 947.72 | ▲ +0.35% | 3,295 |
| Fri, 16 Oct 2026 | 934.01 | 944.39 | 934.01 | 944.39 | ▲ +1.11% | 4,921 |
| Thu, 15 Oct 2026 | 931.52 | 934.01 | 931.52 | 934.01 | ▲ +0.27% | 2,747 |
| Wed, 14 Oct 2026 | 930.25 | 931.52 | 930.25 | 931.52 | ▲ +0.14% | 8,082 |
| Tue, 13 Oct 2026 | 928.23 | 930.25 | 928.23 | 930.25 | ▲ +0.22% | 17,547 |
| Mon, 12 Oct 2026 | 926.50 | 928.23 | 926.50 | 928.23 | ▲ +0.19% | 5,447 |
| Fri, 9 Oct 2026 | 924.78 | 926.50 | 924.78 | 926.50 | ▲ +0.19% | 16,942 |
| Thu, 8 Oct 2026 | 915.21 | 924.78 | 915.21 | 924.78 | ▲ +1.05% | 23,643 |
| Wed, 7 Oct 2026 | 913.25 | 915.21 | 913.25 | 915.21 | ▲ +0.21% | 1,958 |
| Tue, 6 Oct 2026 | 907.09 | 913.25 | 907.09 | 913.25 | ▲ +0.68% | 5,067 |
| Mon, 5 Oct 2026 | 912.09 | 912.09 | 907.09 | 907.09 | ▼ −0.55% | 15,597 |
| Fri, 2 Oct 2026 | 915.16 | 915.16 | 912.09 | 912.09 | ▼ −0.34% | 3,689 |
| Thu, 1 Oct 2026 | 917.44 | 917.44 | 915.16 | 915.16 | ▼ −0.25% | 3,749 |
| Wed, 30 Sep 2026 | 920.77 | 920.77 | 917.44 | 917.44 | ▼ −0.36% | 1,965 |
| Tue, 29 Sep 2026 | 927.73 | 927.73 | 920.77 | 920.77 | ▼ −0.75% | 1,466 |
| Mon, 28 Sep 2026 | 933.39 | 933.39 | 927.73 | 927.73 | ▼ −0.61% | 1,892 |
| Fri, 25 Sep 2026 | 925.16 | 933.39 | 925.16 | 933.39 | ▲ +0.89% | 6,609 |
| Thu, 24 Sep 2026 | 925.40 | 925.40 | 925.16 | 925.16 | ▼ −0.03% | 2,024 |
| Wed, 23 Sep 2026 | 929.66 | 929.66 | 925.40 | 925.40 | ▼ −0.46% | 2,724 |
| Tue, 22 Sep 2026 | 928.66 | 929.66 | 928.66 | 929.66 | ▲ +0.11% | 1,890 |
| Mon, 21 Sep 2026 | 923.72 | 928.66 | 923.72 | 928.66 | ▲ +0.53% | 10,606 |
| Fri, 18 Sep 2026 | 915.37 | 923.72 | 915.37 | 923.72 | ▲ +0.91% | 2,142 |
| Thu, 17 Sep 2026 | 911.18 | 915.37 | 911.18 | 915.37 | ▲ +0.46% | 5,980 |
| Wed, 16 Sep 2026 | 910.00 | 911.18 | 910.00 | 911.18 | ▲ +0.13% | 5,701 |
All figures in PKR, end of day, sourced from the Pakistan Stock Exchange.
ABOT — frequently asked questions
What is ABOT's share price today?
Abbott Laboratories (Pakistan) Limited (ABOT) last traded at Rs 967.16 on the Pakistan Stock Exchange, up 4.65% on the session of 27 October 2026. The day's range was Rs 921.00 to Rs 978.00 on 66,286 shares. These are end-of-day figures published by the exchange, not a live trading feed.
What is the 52-week high and low for ABOT on the PSX?
ABOT has traded between Rs 836.92 and Rs 1,257.76 over the past twelve months on the Pakistan Stock Exchange. The range is computed from the end-of-day closes we hold for the stock and is refreshed after every session.
Is ABOT Shariah-compliant on the PSX?
Yes. The Pakistan Stock Exchange lists ABOT in its Shariah-screened KMI All Share index, which means the company passed the screening set with Meezan Bank at the last review — the business-activity test plus the financial ratio tests on interest-bearing debt, illiquid assets and non-compliant income. Screening is periodic, so a company can be dropped when a ratio breaks; check the current KMI index membership before relying on it.
Which PSX indices is ABOT part of?
ABOT is a constituent of the KSE All Share, KMI All Share and KSE-100. KSE-100 membership means it is one of the hundred companies the headline PSX benchmark is built from. Index membership is taken from the exchange's own published listing for each session.
Is ABOT expensive? What are its valuation ratios?
ABOT trades on a price-to-earnings ratio of 11.1, so the market is paying about Rs 11.1 for each rupee of annual earnings and earnings per share of Rs 81.37. Ratios are only meaningful next to the rest of the sector — a low multiple that the whole sector shares is usually a sector problem rather than a bargain, which is why the sector page is linked from this one.
What is the model outlook for ABOT?
Our model currently reads ABOT as strongly bullish over a short term horizon, at 62% confidence. It is computed from this stock's own price and indicator history. It does not read news, financial statements or management changes, its graded record against the base rate is published on the page, and it is not investment advice.
Answers are generated from the end-of-day figures on this page and refreshed after each session. See all frequently asked questions or our methodology.
About this data
Prices, volumes and indicators for ABOT are end-of-day figures collected from the Pakistan Stock Exchange and recomputed after each session — they are not a live trading feed and may lag the market. Forecasts are the output of logistic-v1, an automated logistic-regression model trained on price history alone; it does not read news, filings or management changes, no analyst reviews its output before publication, and its track record is published in full on our model accuracy page.
PSX Expert is an independent analytics publisher. We are not licensed by the SECP as a securities adviser, investment adviser, research analyst or broker-dealer, and nothing on this page is a personal recommendation. Past performance and back-tested results do not predict future results. Read our methodology, who we are and the full disclaimer before acting on anything here.